---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-361275"
form_type: "8-K"
ticker: "ALXO"
cik: "0001810182"
company_name: "ALX ONCOLOGY HOLDINGS INC"
filed_at: "2021-12-17T23:59:59+00:00"
generated_at: "2026-06-28T00:12:37.635159+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ALX Oncology enters $150M at-the-market stock offering agreement

## Summary
- Entered Sales Agreement with Cantor Fitzgerald and Credit Suisse for ATM offering of up to $150M in common stock.
- Sales may be made at-the-market on Nasdaq or in negotiated transactions; company sets parameters per placement notice.
- Sales Agents receive 3.0% commission per share sold; company not obligated to sell any shares.
- Offering made under existing S-3 shelf registration (filed August 2021); prospectus supplement filed December 17, 2021.

## SEC filing metadata
- accession: 0001193125-21-361275
- form_type: 8-K
- ticker: ALXO
- cik: 0001810182
- company_name: ALX ONCOLOGY HOLDINGS INC
- filed_at: 2021-12-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810182/000119312521361275/0001193125-21-361275-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810182/000119312521361275/d227281d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-361275
- JSON: https://secwatch.observer/filing/0001193125-21-361275.json
- Plain text: https://secwatch.observer/filing/0001193125-21-361275.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.